1998
Association of Antibody to GB Virus C (Hepatitis G Virus) with Viral Clearance and Protection from Reinfection
Thomas D, Vlahov D, Alter H, Hunt J, Marshall R, Astemborski J, Nelson K. Association of Antibody to GB Virus C (Hepatitis G Virus) with Viral Clearance and Protection from Reinfection. The Journal Of Infectious Diseases 1998, 177: 539-542. PMID: 9498429, DOI: 10.1086/514245.Peer-Reviewed Original ResearchConceptsInjection drug usersGBV-C infectionGBV-C RNAViral clearanceGB virus C RNAPositive injection drug usersAssociation of antibodiesGB virus COngoing drug useEnvelope antibodiesRNA testingRNA clearanceDrug usersDrug useVirus CC RNADetectable RNAInfectionClearanceReinfectionPersistent RNAGBVAntibodiesRNAVisits
1997
Syphilis Serology in Human Immunodeficiency Virus Infection: Evidence for False-Negative Fluorescent Treponemal Testing
Erbelding E, Vlahov D, Nelson K, Rompalo A, Cohn S, Sanchez P, Quinn T, Brathwaite W, Thomas D. Syphilis Serology in Human Immunodeficiency Virus Infection: Evidence for False-Negative Fluorescent Treponemal Testing. The Journal Of Infectious Diseases 1997, 176: 1397-1400. PMID: 9359747, DOI: 10.1086/517330.Peer-Reviewed Original ResearchConceptsFTA-ABS testHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionBFP reactionsVirus infectionRapid plasma reagin titerFluorescent treponemal antibody absorption testInjection drug usersAntibody absorption testPresence of antibodiesTreponema pallidum antigensFalse positive reactorsBFP reactorsSyphilis serologySerologic patternTreatment historyDrug usersMembrane antigenTreponemal testingAntigenNegative resultsSyphilisInfectionAntibodiesSerology
1996
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
Shah S, Shapshak P, Rivers J, Stewart R, Weatherby N, Xin K, Page J, Chitwood D, Mash D, Vlahov D, McCoy C. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1996, 11: 301-6. PMID: 8603266, DOI: 10.1097/00042560-199603010-00010.Peer-Reviewed Original ResearchConceptsNeedles/syringesHIV-1 DNAInjection drug usersHIV-1 proteinsHIV-1Polymerase chain reactionClean needlesHuman immunodeficiency virus type 1Immunodeficiency virus type 1Act of injectionVirus type 1Injection paraphernaliaPreliminary laboratory reportDrug usersShooting galleriesType 1Western blotReduction of riskEnvelope geneChain reactionGene DNAAntibodiesSyringesLaboratory reportsModification of behavior
1993
Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland
Vlahov D, Nelson K, Quinn T, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. European Journal Of Epidemiology 1993, 9: 566-569. PMID: 8307145, DOI: 10.1007/bf00209538.Peer-Reviewed Original ResearchDetection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users
Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson K. Detection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users. The Journal Of Infectious Diseases 1993, 168: 327-331. PMID: 8335969, DOI: 10.1093/infdis/168.2.327.Peer-Reviewed Original ResearchConceptsSeronegative intravenous drug usersIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionType 1 infectionPolymerase chain reactionDrug usersHIV-1 infectionHIV-1 antibodiesChain reactionLarge cohortBlood specimensProviral DNAInfectionCohortPCR analysisPersonsSerologyFollowVisitsAntibodiesMonths
1991
Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilitiesDiagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Viscidi R, Hill P, Li S, Cerny E, Vlahov D, Farzadegan H, Halsey N, Kelen G, Quinn T. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 1190-8. PMID: 1941526.Peer-Reviewed Original ResearchConceptsEnzyme immunoassayHTLV-IIAntibody reactivityPeptide enzyme immunoassayHTLV-II infectionEpidemiology of HTLVDifferentiation of HTLVMicrotiter plate enzyme immunoassaysPattern of reactivitySeronegative controlsEmergency departmentEnv peptidesPositive seraViral infectionNeurological diseasesHTLVSynthetic peptidesInfectionDrug abuseMajor envelope proteinEnvEnvelope proteinPatientsSerumAntibodies
1990
ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND
VLAHOV D, MUñOZ A, ANTHONY J, COHN S, CELENTANO D, NELSON K. ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND. American Journal Of Epidemiology 1990, 132: 847-856. PMID: 2239899, DOI: 10.1093/oxfordjournals.aje.a115727.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 seroprevalenceVirus type 1Drug usersInjection careerShooting galleriesType 1Drug injection patternsHIV-1 serostatusHIV-1 infectionRecent onsetDrug injectionHigh riskCommunity outreach effortsDrug useGallery useSame calendar yearSex practicesSeroprevalenceCalendar yearPersistent useAntibodiesPersistent sharingAntibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons
Vlahov D, Lee H, Taylor E, Canavaggio M, Canner C, Burczak J, Saah A. Antibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1990, 3: 531-535. DOI: 10.1097/00126334-199003050-00010.Peer-Reviewed Original ResearchHuman T-Lymphotropic Virus Type I/IIExact testIncoming male inmatesHIV-1 serostatusIntravenous drug usersPrevalence of HTLVFisher's exact testYears of ageSame calendar periodWestern blot techniqueType I/IIEpidemiological serosurveyMale inmatesScope of infectionRisk groupsCalendar periodHIV-1Drug usersHTLVMaryland prisonsBlot techniqueRoutine operational proceduresAntibodiesYear of entrySerostatusSeasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons
Vlahov D, Muñoz A, Brewer F, Taylor E, Canner C, Polk B. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons. AIDS 1990, 4: 345-350. PMID: 2350455, DOI: 10.1097/00002030-199004000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultBlack or African AmericanDistrict of ColumbiaForecastingHealth Planning OrganizationsHispanic or LatinoHIV AntibodiesHIV SeropositivityHIV SeroprevalenceHumansMaleMarylandMultivariate AnalysisPeriodicityPrisonersSeasonsState Health Planning and Development AgenciesSubstance Abuse, IntravenousUnited StatesConceptsIncoming male inmatesHIV-1HIV-1 seroprevalenceHIV-1 infectionEnzyme-linked immunosorbentMultivariate adjustmentPrevious serosurveysSignificant changesBlack raceMale inmatesPrison entrantsMultivariate analysisExcess serumMaryland prisonsWestern blotSeroprevalenceStudy periodAntibodiesDemographic variablesAgeSubgroupsAntibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons
Vlahov D, Lee H, Taylor E, Canavaggio M, Canner C, Burczak J, Saah A. Antibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1990, 3: 531-535. PMID: 1969961, DOI: 10.1097/00126334-199005000-00010.Peer-Reviewed Original ResearchConceptsHuman T-Lymphotropic Virus Type I/IIExact testIncoming male inmatesHIV-1 serostatusIntravenous drug usersPrevalence of HTLVFisher's exact testYears of ageSame calendar periodWestern blot techniqueType I/IIEpidemiological serosurveyScope of infectionMale inmatesCalendar periodRisk groupsHIV-1Drug usersHTLVMaryland prisonsChi 2Blot techniqueRoutine operational proceduresAntibodiesYear of entry